HomeProductsBuilding BlocksHeterocyclic ScaffoldsPiperazinesApitolisib
Chemical structure of CAS 1032754-93-0

Apitolisib

CAS No.1032754-93-0
MDL No.MFCD20274520
MFC23H30N8O3S
MW498.60
InChI KeyYOVVNQKCSKSHKT-HNNXBMFYSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.1032754-93-0
Product NameApitolisib

Biological Targets

PIK3R1·PIK3CB·PIK3CG·PIK3CA·PIK3R2·

Associated Conditions

cancer·prostate cancer·non-Hodgkins lymphoma·breast cancer·renal cell carcinoma·
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Compound Selectivity and Target Residence Time of Kinase Inhibitors Studied with Surface Plasmon Resonance.

Journal of molecular biology • Vol. 429, Issue 4 • 2017
PMID: 28043854DOI: 10.1016/j.jmb.2016.12.019

Discovery of a potent, selective, and orally available class I phosphatidylinositol 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) kinase inhibitor (GDC-0980) for the treatment of cancer.

Journal of medicinal chemistry • Vol. 54, Issue 21 • 2011
PMID: 21981714DOI: 10.1021/jm2009327

The emerging mechanisms of isoform-specific PI3K signalling.

Nature reviews. Molecular cell biology • Vol. 11, Issue 5 • 2010
PMID: 20379207DOI: 10.1038/nrm2882

mTOR signaling at a glance.

Journal of cell science • Vol. 122, Issue Pt 20 • 2009
PMID: 19812304PMC: PMC2758797DOI: 10.1242/jcs.051011

Documentation

Similar Products